NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)
$67.1 0.79 (1.1914%)
Analysed NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) News Sources
Novonesis to build next generation enzyme production facility in India
02-09-2026
yahoo.com
Initiation of Novonesis’ share buyback program
14-09-2026
yahoo.com
Novozymes (CPSE:NSIS B) Could Be 13% Undervalued After €600 Million Patalganga Expansion
14-09-2026
yahoo.com
Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing
28-09-2026
yahoo.com
Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities
01-10-2026
yahoo.com
Novonesis Opens Doors to Students to Inspire the Next Generation of U.S. Biomanufacturing Talent
15-10-2026
yahoo.com
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
16-04-2026
yahoo.com
FUL vs. NVZMY: Which Stock Is the Better Value Option?
07-08-2026
yahoo.com
FUL or NVZMY: Which Is the Better Value Stock Right Now?
24-08-2026
yahoo.com
Novonesis (Novozymes) B's Dividend Analysis
31-08-2026
yahoo.com
What is the current price of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)?
The current price of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) is $67.1.
NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) since the previous trading day is $0.79.
NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) since the previous trading day is 1.1914%.
What is the most recent average sentiment score for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)?
The most recent average sentiment score for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) is 53 out of 100.
What is the most recent average sentiment for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)?
The most recent sentiment for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) is .
SEC-8K** Filing Available For NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.